Back to mobile site

Wells Fargo Upgrades Relay Therapeutics (RLAY) to Overweight

December 12, 2025 5:08 AM EST
Get Alerts RLAY Hot Sheet
Price: $17.44 +0.93%

Rating Summary:
    15 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE

Wells Fargo analyst Eva Fortea Verdejo upgraded Relay Therapeutics (NASDAQ: RLAY) from Equal Weight to Overweight with a price target of $13.00.

For an analyst ratings summary and ratings history on Relay Therapeutics click here. For more ratings news on Relay Therapeutics click here.

Shares of Relay Therapeutics closed at $7.79 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Wells Fargo, Maynard Um, Mark Zuckerberg, ARK